Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Rheumatology International|March 25, 2014
Sarcoidosis and the occurrence of malignant diseasesNorbert Blank, Hanns-Martin Lorenz, Anthony D Ho, et al.
Frontiers in Oncology|May 30, 2017
The Oncolytic Virotherapy Era in Cancer Management: Prospects of Applying H-1 Parvovirus to Treat Blood and Solid CancersAssia L Angelova, Mathias Witzens-Harig, Angel S Galabov, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 23, 2015
Nonpegylated Liposomal Doxorubicin as a Component of R-CHOP Is an Effective and Safe Alternative to Conventional Doxorubicin in the Treatment of Patients With Diffuse Large B-Cell Lymphoma and Preexisting Cardiac DiseasesSarah Rohlfing, Matthias Aurich, Tilman Schöning, et al.
Leukemia & Lymphoma|April 10, 2008
Cellular immune responses against the cancer-testis antigen SPAN-XB in healthy donors and patients with multiple myelomaChristian Frank, Michael Hundemer, Anthony D Ho, et al.
International Journal of Cancer|August 12, 2015
HTLV-1-associated adult T cell leukemia is highly susceptible to Navitoclax due to enhanced Bax expressionMathias Witzens-Harig, Marco Giaisi, Rebecca Köhler, et al.
Leukemia & Lymphoma|March 22, 2016
Analysis of clinical characteristics and outcome of patients with previously untreated diffuse large B-cell lymphoma and renal involvement in the rituximab eraNicola Lehners, Isabelle Krämer, Mark-Alexander Schwarzbich, et al.
European Journal of Haematology|September 7, 2018
NKT cells - New players in CAR cell immunotherapy?Katharina Kriegsmann, Mark Kriegsmann, Michael von Bergwelt-Baildon, et al.
BMC Cancer|February 15, 2017
Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvementNicola Lehners, Isabelle Krämer, Maral Saadati, et al.
Leukemia & Lymphoma|September 23, 2010
Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapyJuliane Brandt, Sascha Dietrich, Julia Meissner, et al.
Annals of Hematology|July 3, 2017
The influence of rituximab-containing chemotherapy on HCV load in patients with HCV-associated non-Hodgkin's lymphomasXiang Zhou, Katharina Lisenko, Nicola Lehners, et al.
Pageof 8